Purpose
to evaluate in vivo efficacy of novel chemical matter in the TB Drug Accelerator (TBDA) drug discovery pipeline to deliver compounds and regimen that contribute to the development of safer, simpler and shorter universal TB treatment regimen
Grantee
Division
Global Health
Date
AUGUST 2026
Region served
GLOBAL
Committed amount
$2,678,750
Grant topic
Tuberculosis
Duration (months)
35
Grantee location
Rondebosch, Western Cape, South Africa
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.